Evidence map›Paper›PMID 41066594›Full record

ReviewEuropace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology2025

A review on wearable cardioverter-defibrillators in clinical practice for sudden cardiac death prevention and heart failure management.

David Duncker, Rodrigue Garcia, Diana Bonderman, Giancarlo Casolo, Michał Farkowski, Carsten Israel, Eloi Marijon

Abstract readReview
In one paragraph

Review in Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Incidence and predictors of major arrhythmic events after myocarditis: a systematic review and meta-analysis.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026
    Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

David DunckerHannover Heart Rhythm Center, Department of Cardiology and Angiology, Hannover Medical School, Carl-Neuberg-Str. 1, Hannover 30625, Germany.ORCID 0000-0003-2996-6338
Rodrigue GarciaDepartment of Cardiology, University Hospital of Poitiers, Poitiers 86000, France.ORCID 0000-0001-9350-2437
Diana BondermanDepartment of Internal Medicine with Cardiology and Emergency Medicine, Favoriten Clinic, Wiener Gesundheitsverbund, Vienna, Austria.ORCID 0000-0002-6885-5924
Giancarlo CasoloDepartment of Medicine, Cardiology Unit, Versilia Hospital, Lido di Camaiore, Italy.ORCID 0000-0003-3094-9391
Michał FarkowskiDepartment of Cardiology, Ministry of Interior and Administration National Medical Institute, Warsaw, Poland.ORCID 0000-0003-1673-7712
Carsten IsraelDepartment of Medicine-Cardiology, Diabetology and Nephrology, Bethel-Clinic, Bielefeld, Germany.ORCID 0000-0003-1101-7556
Eloi MarijonDivision of Cardiology, European Georges Pompidou Hospital, Paris, France.ORCID 0000-0001-7227-3428

Funding

ZOLL
6 · The paper itself

Abstract

Sudden cardiac death (SCD) remains a predominant mode of death in cardiovascular mortality. Despite advancements in guideline-recommended medical therapy and risk stratification, accurately identifying patients who would benefit most from implantable cardioverter-defibrillator (ICD) therapy over the long term remains a significant challenge. The wearable cardioverter-defibrillator (WCD) has emerged as a non-invasive bridge to either ICD implantation or recovery of left ventricular function. This expert review presents a comprehensive and up-to-date summary of clinical evidence on WCD use for SCD prevention and heart failure (HF) management. Specifically, it will address: (i) the concept and mechanism of the WCD; (ii) evidence from randomized and observational studies regarding efficacy, safety, and cost-effectiveness; (iii) integration of the WCD into HF management; and (iv) knowledge gaps and priorities for future research.

Indexed as

Death, Sudden, CardiacDefibrillatorsElectric CountershockHeart FailureWearable Electronic DevicesDefibrillators, ImplantableHumansRisk FactorsTreatment OutcomeICDImplantable cardioverter-defibrillatorSudden cardiac deathWearable cardioverter-defibrillator

Identifiers

PMID41066594
PMCPMC12629875

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.